Pharmaceutical composition for preventing and treating qi and blood deficiency type recurrent abortion
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 陈红
- Publication Date
- 2016-06-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the technical field of traditional Chinese medicine, and relates to a pharmaceutical composition for preventing and treating recurrent miscarriage due to deficiency of qi and blood and a preparation method thereof. Background technique
[0002] Recurrent spontaneous abortion (RSA) refers to those with the same sexual partner who have suffered 2 or more consecutive losses of fetuses (weight ≤ 500g) before 20 weeks of gestation. According to statistics from different regions, different classes and different ages, the incidence of spontaneous abortion is about 15%-40%, and RSAR accounts for more than 5% of women in childbearing period. In the past ten years, its incidence has been increasing year by year. The disease can lead to infertility, seriously affecting the patient's physical and mental health and even the stability of the family.
[0003] Modern medicine believes that the basic pathology of recurrent miscarriage is that...